beta-Hydroxy Tetrabenazine-D7

Beta-Hydroxy Tetrabenazine-D7 is a deuterated version of tetrabenazine, a medication that is primarily used to treat movement disorders such as Huntington's disease and tardive dyskinesia. Tetrabenazine works by reducing the levels of dopamine in the brain, which helps to alleviate the involuntary movements and muscle spasms associated with these conditions. Beta-Hydroxy Tetrabenazine-D7, on the other hand, is a labeled form of tetrabenazine that contains seven deuterium atoms. This labeling can be useful in scientific research, as it allows for the tracking of the drug's metabolism and distribution in the body. In terms of its chemical properties, Beta-Hydroxy Tetrabenazine-D7 has a molecular formula of C19H19D7NO3 and a molecular weight of 324.46 g/mol. It is a white to off-white powder that is soluble in water and organic solvents such as ethanol and methanol. The recommended dosage and administration of Beta-Hydroxy Tetrabenazine-D7 will depend on the specific research application, and should be determined by a qualified researcher or medical professional. As with any medication, it is important to follow proper handling and storage procedures to ensure the stability and efficacy of the product.